长期使用Abemaciclib导致呼吸困难和死亡:一个案例报告
Jonathan T Burrows1, Rebekah Lantz2
1Internal Medicine, Wright State University Boonshoft School of Medicine, Dayton, USA.
检查点抑制性肺炎 (CIP) 是癌症免疫治疗的罕见但致命的并发症,特别是使用PD-1抑制剂. 早期识别和专家参与对于管理这种严重的呼吸道疾病至关重要.
科学领域:
- 在瘤学瘤学.
- 肺部病理学 肺部病理学
- 免疫治疗是一种免疫疗法.
背景情况:
- 检查点抑制性肺炎 (CIP) 是与癌症免疫疗法相关的严重不良事件.
- 编程死亡1 (PD-1) 抑制剂与较高的CIP发病率有关.
- 患者经常出现非特异性呼吸道症状,延迟诊断.
研究的目的:
- 突出检查点抑制性肺炎的危急性和潜在致命性.
- 强调早期识别和治疗癌症患者中CIP的重要性.
- 强调患者和家庭对免疫治疗副作用的教育.
主要方法:
- 一位82岁的拉丁裔妇女患有ER+/HER2-球状乳腺癌的病例报告.
- 审查患者的治疗史,包括激素治疗,放射治疗,CMF和PD-1抑制剂治疗.
- 分析临床表现,诊断工作和急性呼吸困扰综合征 (ARDS) 发展后的结果.
主要成果:
- 患者出现了渐进的呼吸不全和咳,导致住院治疗,怀疑患有多焦点肺炎和败血症.
- 她迅速发展为ARDS,需要机械通风,最终导致死亡.
- 临床过程与检查点抑制性肺炎的致命呈现一致.
结论:
- 虽然很少见,但CIP的死亡率很高,特别是当ARDS发展时.
- 专家的早期参与和关于潜在副作用的明确沟通对于改善结果至关重要.
- 积极的患者教育和及时干预对于在癌症治疗期间管理CIP至关重要.
更多相关视频
05:19Author Spotlight: An Effective Traditional Chinese Medicinal Treatment for Chronic Obstructive Pulmonary Disease with Abdominal Distension
Published on: September 1, 2023
02:34Author Spotlight: Efficacy of Auricular Pressure Bean Therapy in Reducing Wheezing Symptoms
Published on: May 10, 2024
相关概念视频
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Chronic Obstructive Pulmonary Disease-I: Introduction
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
COPD: Management Using Bronchodilators and Corticosteroids
